Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze CDTX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CDTX investment potential.

What is CDTX stock price today?

Get real-time CDTX stock price, historical data, and price charts on Financhill. Track CDTX performance with our advanced analysis tools.

Is CDTX a good investment?

Evaluate CDTX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CDTX stock?

To buy CDTX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CDTX?

View detailed market capitalization data and company valuation metrics for CDTX on our comprehensive analysis page.

What is the P/E ratio of CDTX?

Use our fundamental analysis tools to view CDTX P/E ratio and compare valuation metrics with industry peers.

What are CDTX earnings?

View CDTX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Cidara Therapeutics, Inc. Stock Predictions

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

CDTX
Cidara Therapeutics, Inc.

Last Price:

$220.34

Seasonality Move:

5.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Still Time to Get In: RAD Intel at $0.85/Share

Cidara Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Cidara Therapeutics, Inc. has on average historically risen by 88.1% based on the past 10 years of stock performance.
Cidara Therapeutics, Inc. has risen higher in 3 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
Is Cidara Therapeutics, Inc. Stock Undervalued?

The current Cidara Therapeutics, Inc. [CDTX] share price is $220.50. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Cidara Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Cidara Therapeutics, Inc. has on average historically risen by 88.1% based on the past 10 years of stock performance.

Cidara Therapeutics, Inc. Stock Rating

Buy

Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. overpriced?

Cidara Therapeutics, Inc. has risen higher in 3 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%

Cidara Therapeutics, Inc. Stock Price History

Is CDTX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

cidara.com

52-Week Data

52-Week High:

221.20

52-Week Low:

15.22

Prediction Charts

Market Cap:

6.9B

Price in USD:

220.50

Volume:

453.5K

Beta:

1.55

Technical Analysis

SMA50:

134.84

SMA100:

99.56

SMA200:

62.90

52-Wk Change:

1005.26%

Stock Predictions

Is Cidara Therapeutics, Inc. stock public?

Yes, Cidara Therapeutics, Inc. is a publicly traded company.
What is the Cidara Therapeutics, Inc. stock quote today?

The Cidara Therapeutics, Inc. stock price is 220.50 USD today.
How to buy Cidara Therapeutics, Inc. stock online?

You can buy Cidara Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	217.20	217.71	218.85	216.80
Nov-17	217.41	217.91	218.77	217.41
Nov-18	218.00	218.41	218.84	217.76
Nov-19	218.35	219.02	219.64	218.35
Nov-20	219.25	219.55	220.41	219.03
Nov-21	219.45	219.35	219.90	218.86
Nov-24	219.60	220.25	220.46	219.04
Nov-25	220.04	219.65	220.22	219.50
Nov-26	219.90	219.75	219.98	219.51
Nov-28	219.61	219.88	219.88	219.40
Dec-1	219.71	219.73	220.10	219.36
Dec-2	219.65	219.89	219.94	219.65
Dec-3	219.89	220.98	221.20	219.74
Dec-4	220.08	220.50	220.69	219.86

Cidara Therapeutics, Inc. Earnings

Cidara Therapeutics, Inc. Earnings Report: Per Share Cidara Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cidara Therapeutics, Inc. Forecast Revenue Growth

Cidara Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Cidara Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

* Cidara Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.